Benzinga's M&A Chatter for Tuesday November 4, 2014

Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday November 4, 2014:
MasterCard Acquires 5one Marketing; Terms Not DisclosedThe Deal
:

MasterCard
MA
today announced it has acquired global consultancy company, 5one Marketing Limited. Terms of the deal were not disclosed. MasterCard closed Tuesday at $83.99, a loss of $0.14.
Lindsay Corporation to Acquire Elecsys Corporation for $17.50.Share in CashThe Deal
:

Lindsay Corporation
LNN
announced Tuesday that it has agreed to acquire Elecsys Corporation
ESYS
for $17.50 per share in cash, for a total purchase price of approximately $70.5 million. The agreement has been unanimously approved by the Boards of Directors of both companies and is tareget for closing in January 2015. Elecsys Corporation closed Tuesday at $9.57, and traded over $17.00 after-hours.
EnerNOC to Acquire World Energy Solutions for $5.50/Share in CashThe Deal
Loading...
Loading...
:

EnerNOC, Inc.
ENOC
announced Tuesday, that it has agreed to acquire World Energy Solutions, Inc.
XWES
for $5.50 per share, plus the assumption of debt, for a total transaction value of approximately $76 million in cash. The Boards of Directors of both companies have approved the transaction, which is expected to close in Q1 of 2015. World Energy Solutions closed Tuesday at $4.15, and traded at $5.30 after-hours.
Valeant, Pershing Square May Vote at Special MeetingThe Court Ruling
:

The United States District Court for the Central District of California, on Tuesday, held that Pershing Square Capital Management, L.P., Valeant Pharmaceuticals International, Inc.
VRX
and related parties may vote shares of Allergan, Inc.
AGN
or proxies at the upcoming December 18 stockholder meeting. Allergan said in a statement it will file an emergency appeal. Allergan had sought a court order to block Valeant and Pershing from voting their shares and accused them of violating securities regulations. Allergan has turned down an offer of $53 billion from the parties. Valeant said on October 27, it was prepared to raise its offer to provide Allergan shareholders with at least $200 per share in value. Allergan shares gained 1% Tuesday, to close at $195.12, while Valeant gained $0.76, to close at $133.61.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHedge FundsMovers & ShakersLegalManagementM&AMoversGeneralConstruction & Farm Machinery & Heavy TrucksData Processing & Outsourced ServicesIndustrialsInformation Technology
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...